GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com
Patient Information Leaflet last updated on the eMC: 18/11/2008
PIL ReQuip XL prolonged-release tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 18/11/2008 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
Updated on 28/05/2008 and displayed until 18/11/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   ropinirole hydrochloride


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk